Longitudinal assessment of circulating cytokine profile of severe alcohol-associated hepatitis
Circulating cytokine and immune biomarkers dynamically change in AH during treatment, disease progression and/or resolution. Our results highlight the importance of treatment-specific biomarkers in future clinical trials.
Authors
- G. Szabó (ORCID: https://orcid.org/0000-0002-3409-5357)
- M. Ellen Mitchell
- Dávid Tornai (ORCID: https://orcid.org/0000-0002-1335-5498)
- Bruce Barton (ORCID: https://orcid.org/0000-0001-7878-8895)
- Craig J. McClain
- Srinivasan Dasarathy
Institutions
- Beth Israel Deaconess Medical Center (US)
- Cleveland Clinic (US)
- University of Debrecen (HU)
- Harvard University (US)
- University of Massachusetts Chan Medical School (US)
- Cleveland Clinic Lerner College of Medicine (US)
- Louisville VA Medical Center (US)
- The University of Texas Southwestern Medical Center (US)
Publication Details
- Journal
- Hepatology
- Published
- 2026-03-13
- DOI
- https://doi.org/10.1097/hep.0000000000001743
- Primary Topic
- Alcohol Consumption and Health Effects
- Type
- article
- Field-Weighted Citation Impact
- 0.00